抗血小板疗法在急性心肌梗塞中,由心脏性休克症复杂化
Angela Dettling1,2,3, Kurt Huber4, Steen D Kristensen5
1Department of Cardiology, University Medical Center Hamburg-Eppendorf, Martinistr. 52, 20246, Hamburg, Germany. a.dettling@uke.de.
概括
对心脏病发作后患有心脏性休克 (CS) 的患者来说,管理血栓至关重要. 在平衡有效的抗血栓治疗以预防血栓并最大限度地降低出血风险的同时,平衡有效的抗血栓治疗是改善这些高危人群生存的关键.
科学领域:
- 心脏病学 心脏病学
- 药理学 药理学是指药理学的学科.
背景情况:
- 心脏性休克 (CS) 导致急性心肌梗塞 (AMI) 的并发症,死亡率很高,约为50%.
- 有效的抗血栓治疗对于改善急性冠状动脉综合征的结果至关重要,特别是在高风险的冠状动脉综合征患者中.
- 脑脊髓病患者面临着血栓和出血并发症的双重风险,使治疗决策复杂化.
研究的目的:
- 审查目前的实践和挑战在AMI与CS的抗血栓治疗中.
- 为了评估抗血小板和抗血栓剂在这个人群中的安全性,有效性和结果.
- 讨论亲肠道血小板抑制剂在控制CS中的作用.
主要方法:
- 对CS中抗血栓治疗现有证据的文献综述.
- 分析影响药物有效性和安全性的因素,包括药物管理,新陈代谢和机械循环支持 (MCS).
- 专注于辅助的抗血小板和抗血栓策略.
主要成果:
- 在CS中平衡抗血栓治疗是具有挑战性的,因为血栓形成和出血的风险很高.
- 机械循环支持 (MCS) 在管理抗血栓治疗方案方面引入了进一步的复杂性.
- 腹腔血小板抑制剂被讨论为一种潜在的治疗选择.
结论:
- 在AMI与CS中优化抗血栓治疗需要仔细考虑个体患者的风险因素.
- 需要进一步的研究,以建立最佳策略来平衡有效性和安全性.
- 对抗血栓管理的个性化方法对于改善CS患者的存活率至关重要.
相关概念视频
01:20Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
454
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
454
01:25Antianginal Drugs: Calcium Channel Blockers and Ranolazine
437
Angina pectoris, a primary symptom of ischemic heart disease, requires careful pharmacological interventions. In this context, calcium channel blockers (CCBs) and ranolazine have emerged as crucial pharmacotherapeutic agents, providing deep insights into the complexities of angina management.
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...
437
01:26Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers
126
Receptor tyrosine kinase inhibitors (TKIs) and calcium channel blockers (CCBs) are two critical categories of drugs employed in the treatment of pulmonary artery hypertension (PAH). PAH is a disease that causes high blood pressure in the pulmonary arteries, resulting in chest pain, fatigue, and shortness of breath.
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
126
01:30Anticoagulant Drugs: Low-Molecular-Weight Heparins
590
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
590
01:24Blood Pressure Imbalances and Circulatory Shock
729
Disorders affecting blood volume, vascular tone, or vascular function can disrupt vascular homeostasis, including conditions like hypertension, hemorrhage, and shock.
Blood Pressure: Hypertension and Hypotension
Normal blood pressure is 120/80 mm Hg. Elevated blood pressure is 120-129/under 80 mm Hg. Hypertension, warranting treatment at 130/80 mm Hg, is often asymptomatic and can lead to severe cardiovascular events, aneurysms, peripheral arterial disease, chronic renal disease, or cardiac...
Blood Pressure: Hypertension and Hypotension
Normal blood pressure is 120/80 mm Hg. Elevated blood pressure is 120-129/under 80 mm Hg. Hypertension, warranting treatment at 130/80 mm Hg, is often asymptomatic and can lead to severe cardiovascular events, aneurysms, peripheral arterial disease, chronic renal disease, or cardiac...
729
01:22Formation of the Platelet Plug
3.7K
The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
3.7K